Published in Arch Mal Coeur Vaiss on September 01, 1977
Cardiac valve surgery--the "French correction". J Thorac Cardiovasc Surg (1983) 5.82
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet (2000) 5.04
Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg (1992) 3.69
Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg (1980) 2.97
Cardiac hemangiomas. Ann Thorac Surg (1993) 2.67
Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol (1986) 2.64
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology (2007) 2.52
Elastase-induced experimental aneurysms in rats. Circulation (1990) 2.50
Endoscopic coronary artery bypass grafting with the aid of robotic assisted instruments. J Thorac Cardiovasc Surg (1999) 2.46
A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg (1971) 2.32
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut (2002) 2.31
Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg (1999) 2.24
Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation (2001) 2.20
Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg (2001) 2.16
Acute myocardial infarction: can it be a complication of acute organophosphorus compound poisoning? J Postgrad Med (2013) 2.15
Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg (1969) 2.04
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer (2001) 1.95
The surgical treatment of constrictive fibrous endocarditis. Ann Surg (1976) 1.81
P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res (2001) 1.74
The aorta-to-coronary radial artery bypass graft. A technique avoiding pathological changes in grafts. Ann Thorac Surg (1973) 1.71
A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol (1999) 1.67
Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group. Int J Radiat Oncol Biol Phys (1996) 1.63
Homograft replacement of the mitral valve. Graft selection, technique of implantation, and results in forty-three patients. J Thorac Cardiovasc Surg (1996) 1.60
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant (2011) 1.57
Cardiac pheochromocytomas. Ann Thorac Surg (1992) 1.55
Left ventricular outflow tract obstruction after mitral valve repair. Results of the sliding leaflet technique. Circulation (1993) 1.52
p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma. Oncology (2000) 1.52
The radial artery for coronary artery bypass grafting: clinical and angiographic results at five years. J Thorac Cardiovasc Surg (1998) 1.49
Valve repair with Carpentier techniques. The second decade. J Thorac Cardiovasc Surg (1990) 1.49
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest (1988) 1.48
Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Crit Care Med (1999) 1.48
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data. Pathology (2015) 1.47
Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis (1999) 1.46
Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr (2009) 1.45
Pathology reporting of breast cancer: trends in 1989-1999, following the introduction of mammographic screening in Western Australia. Pathology (2005) 1.44
Peripheral vascular involvement in heart transplant patients. Ann Vasc Surg (1994) 1.43
Angiographic and electron-beam computed tomography studies of retrograde cardioplegia via the coronary sinus. J Thorac Cardiovasc Surg (1996) 1.43
Congenital malformations of the mitral valve in children. Pathology and surgical treatment. J Thorac Cardiovasc Surg (1976) 1.42
[Ascending aortic ectasia. New reinforcement technique]. Presse Med (1991) 1.39
[Chronic meningitis before diagnosis of celiac disease]. Rev Neurol (Paris) (2002) 1.39
Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease. Crit Care Med (1999) 1.39
Early extubation after mitral valve surgery: a target-controlled infusion of propofol and low-dose sufentanil. J Cardiothorac Vasc Anesth (1997) 1.38
Pre-operative chemo-radiotherapy in locally advanced rectal cancer: is this the way of future management? Australas Radiol (1999) 1.38
Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol (1990) 1.38
Effects of cardioplegic solutions on the vasoreactivity of the internal mammary artery. Ann Thorac Surg (1998) 1.37
Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg (2000) 1.35
Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg (1974) 1.35
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest (1999) 1.35
Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation (2001) 1.34
Initial chemotherapy in gliomatosis cerebri. Neurology (2004) 1.33
Surgical treatment of constrictive fibrous endocarditis. J Thorac Cardiovasc Surg (1981) 1.32
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32
Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. QJM (1996) 1.31
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation. Eur J Cancer (2000) 1.29
Combined coronary and femoral revascularization using an ascending aorta to bifemoral bypass. Arch Surg (1994) 1.28
Effect of acute moderate changes in PaCO2 on global hemodynamics and gastric perfusion. Crit Care Med (2000) 1.28
Left ventricular outflow obstruction after mitral valve repair (Carpentier's technique). Proposed mechanisms of disease. Circulation (1988) 1.27
Conservative management of the prolapsed mitral valve. Ann Thorac Surg (1978) 1.27
Management of pseudoaneurysm of the ascending aorta performed under circulatory arrest by port-access. Ann Thorac Surg (2001) 1.27
[Fibrous endocarditis of the left ventricle in a patient with filariasis; surgical cure]. Arch Mal Coeur Vaiss (1973) 1.25